Against a backdrop of global pandemic, the critical need for trusted health evidence has never been clearer. That’s where Cochrane comes in…
Cochrane is an independent, not-for-profit research network of over 40,000 people across 130 countries. For over 20 years, we’ve provided the highest quality health evidence for people, governments and organisations around the globe - from the World Health Organisation to Wikipedia.
Our evidence is recognised as the international gold standard for health information because we don’t accept commercial sponsorship and our scientific methods are second to none. We publish our findings in the form of ‘systematic reviews’. This means that rather than cherry-picking findings from one or two studies, we systematically weigh up all of the available studies on a specific health question or topic - with an eye to how each study is conducted and funded. All our reviews are published online in the Cochrane Library.
The Australian Government funds a national subscription to the Cochrane Library, and collectively Australians download more Cochrane reviews each year than any other nation. From our centre in Melbourne, Cochrane Australia provides training and support to over 3,000 local Cochrane contributors and shares the latest in health news with the broader Australian community.
Given the age of both pandemic and infodemic that we find ourselves living in, we know our contribution to producing the world’s most trusted health evidence has never been more critical.
Latest news, reviews & events
WHO rapid review: clear communication critical in the battle against COVID-19
It’s hard to believe that just over a year ago, lockdowns, quarantining and strict social distancing were completely unfamiliar to us. Yet in a matter of months…
New Cochrane review explores the latest evidence on approaches to stopping long term antidepressants
There are many reasons to undertake a Cochrane review. For the author team behind the new review on safe and effective approaches to stopping antidepressants, the motivating factors were both personal and professional, national and international.
Engaging Evidence 2021 /
Evolving Approaches
Evidence has taken centre stage around the globe over this past year. Practitioners, patients, policy makers, politicians, the media and the public continue to grapple with how to use and communicate evidence in a time of uncertainty.
Medical student relay delivers a new Cochrane review & plenty of practical knowledge
Mindfulness has been growing in popularity across the globe over the past decade, and is increasingly the subject of scientific research into the benefits it may deliver. +more
Victorian Government to invest in Australian Living Evidence Consortium
Cochrane Australia and the Australian Living Evidence Consortium have welcomed the announcement that the Victorian Government will invest in the ‘Living Evidence’ model to transform the way new research is used to improve outcomes for patients in Victoria and around Australia.
Featured Podcasts
Feature
Cochrane COVID-19 Editorial: Policy makers must act on incomplete evidence
Reducing the transmission of Coronavirus disease 2019 (COVID-19) is a global priority. To this end, public health officials and politicians across the world have been seeking scientific expertise to guide policy. In response, investigators have rushed to share new results on preprint servers, and journals have expedited editorial and peer review processes to publish them. The urgency to define the relevant knowledge base in preventing, diagnosing, and managing COVID-19 infection has required intense collaboration in evidence generation and synthesis, in order to provide public health officials with authoritative guidance.
A newly published Cochrane Library Editorial outlines how Cochrane has responded to the COVID-19 pandemic, what the limitations of COVID-19 evidence are, and how policy makers can move forward with best available evidence. This Editorial publishes alongside the updated Cochrane Review Physical interventions to interrupt or reduce the spread of respiratory viruses.
Infodesk
New Cochrane review explores the latest evidence on approaches to stopping long term antidepressants
There are many reasons to undertake a Cochrane review. For the author team behind the new review on safe and effective approaches to stopping antidepressants, the motivating factors were both personal and professional, national and international.
New Cochrane review explores the latest evidence on approaches to stopping long term antidepressants
There are many reasons to undertake a Cochrane review. For the author team behind the new review on safe and effective approaches to stopping antidepressants, the motivating factors were both personal and professional, national and international.
Question:
Can Omega-3 fatty acids reduce the risk of premature birth?
Question:
Cochrane who?
Question:
Does using antibiotics to treat middle ear infection do more harm than good?
Feature 1
Vivamus a ante congue, porta nunc nec, hendrerit turpis. In sit amet felis malesuada, feugiat purus eget, varius mi. Donec ac fringilla turpis.
Feature 2
Sed a ligula quis sapien lacinia egestas. Nullam sit amet nisi condimentum erat iaculis auctor. Nullam sit amet nisi condimentum erat iaculis auctor.
Feature 3
Donec eu est non lacus lacinia semper. Quisque congue porttitor ullamcorper. In sit amet felis malesuada, feugiat purus eget, varius mi.